PODD
Insulet Corporation
Latest News for PODD
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insulet (PODD – Research Report) and Resmed (RMD – R......
Growth stocks reflect firms on track for swift expansion, beating peers and the overall market. Their strategy to reinvest profits drives continued......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioAge Labs, Inc. (BIOA – Research Report) and Ins......
In a report released today, Patrick Wood from Morgan Stanley maintained a Buy rating on Insulet, with a price target of $370.00. Wood covers the He......
In a report released today, Richard Newitter from Truist Financial reiterated a Buy rating on Insulet, with a price target of $412.00. Newitter cov......
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Insulet yesterday and set a price target of $380.00. The company’s shares closed......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PODD | $295.70 | +0.5% | 576.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |